A massive recall of Walgreens nasal spray threatens consumer safety as over 41,000 bottles are suspected of bacterial contamination.
Story Highlights
- The FDA has recalled over 41,000 bottles of Walgreens nasal spray due to contamination concerns.
- The recall affects specific lots of Walgreens Saline Nasal Spray with Xylitol.
- Consumers are advised to return affected products for a full refund.
- A Class II recall indicates potential health risks, though serious consequences are unlikely.
FDA Issues Nationwide Recall of Walgreens Nasal Spray
In November 2025, the Food and Drug Administration (FDA) announced the recall of 41,328 bottles of Walgreens nasal spray due to possible contamination with pseudomonas lactis, a bacterium typically found in raw milk. This recall specifically targets 1.5-oz bottles of Walgreens Saline Nasal Spray with Xylitol, raising concerns about product safety and consumer health nationwide.
Walgreens, upon guidance from the FDA, initiated this voluntary recall to prioritize customer safety. The recall involves two specific lots, 71409 and 71861, which have expiration dates extending to 2027. These products were distributed across various Walgreens locations throughout the country. Customers in possession of these nasal sprays are urged to return them for a full refund.
💊 CHECK YOUR CABINET: The FDA announced a recall of 41,000+ bottles of Walgreens Saline Nasal Spray with Xylitol over possible bacterial contamination.https://t.co/vHsbLtvj3F
— Fox News (@FoxNews) November 25, 2025
Understanding the Class II Recall
The FDA has classified this incident as a Class II recall, which suggests that while exposure to the contaminated product may lead to temporary or reversible health consequences, the likelihood of severe health outcomes is remote. Despite the low probability of serious effects, this measure highlights the importance of safety in pharmaceutical products and the ongoing vigilance required to protect public health.
The recall was initiated as a precautionary step, underscoring Walgreens’ commitment to consumer safety. The company’s spokesperson emphasized that the decision was made out of an abundance of caution, reflecting the retailer’s proactive approach in addressing potential health risks.
CDC Guidelines and Flu Season Preparations
Coinciding with the recall, the Centers for Disease Control and Prevention (CDC) has released its annual flu season guidelines. The CDC recommends that everyone over six months of age receive a flu vaccine, particularly those at higher risk of serious complications. These guidelines aim to reduce flu transmission and protect vulnerable populations.
To mitigate the spread of the flu, the CDC advises maintaining good hygiene practices, such as frequent handwashing, and recommends that sick individuals avoid close contact with healthy individuals. These measures, alongside vaccination, form a comprehensive strategy to combat flu season effectively.
